Journal Articles

A breakthrough in the management of neuro-ischaemic diabetic foot ulcers

Share this article

A breakthrough in the management of neuro-ischaemic diabetic foot ulcers

Emilio Galea
6 June 2018

In a growing proportion of diabetic foot ulcers are being diagnosed as neuro-ischaemic. Management of this type of wound is complex, requiring prompt referral, debridement where indicated, appropriate footwear, offloading, dressings and the treatment of infection. Until recently, no drug or device had been demonstrated to effectively treat neuro-ischaemic foot ulcers. The discovery that matrix metalloproteinases are involved has led to the identification and study of nano oligosaccharide factor, which shows promise  in treating this challenging condition. 

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.